Home/Filings/4/0001209191-21-040984
4//SEC Filing

North Annette 4

Accession 0001209191-21-040984

CIK 0001595893other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:16 PM ET

Size

13.3 KB

Accession

0001209191-21-040984

Insider Transaction Report

Form 4
Period: 2021-06-15
North Annette
EVP, General Counsel & Secty.
Transactions
  • Sale

    Common Stock

    2021-06-15$77.37/sh2,700$208,89918,999 total
  • Sale

    Common Stock

    2021-06-15$77.82/sh6,634$516,25812,365 total
  • Exercise/Conversion

    Common Stock

    2021-06-15$17.00/sh+15,000$255,00027,365 total
  • Sale

    Common Stock

    2021-06-15$75.94/sh5,666$430,27621,699 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-06-1515,000154,609 total
    Exercise: $17.00Exp: 2029-04-14Common Stock (15,000 underlying)
Footnotes (5)
  • [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
  • [F2]The weighted average sale price for the transaction reported was $75.94, and the range of prices were between $75.49 and $76.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F3]The weighted average sale price for the transaction reported was $77.37, and the range of prices were between $76.575 and $77.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F4]The weighted average sale price for the transaction reported was $77.82, and the range of prices were between $77.59 and $78.21. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F5]One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.

Issuer

Turning Point Therapeutics, Inc.

CIK 0001595893

Entity typeother

Related Parties

1
  • filerCIK 0001341011

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:16 PM ET
Size
13.3 KB